Rockville, Maryland — September 29, 2026 The global blood sugar tester market is estimated at USD 16.1 billion in 2026 and is projected to reach USD 29.4 billion by 2036, expanding at a CAGR of 6.2% during the forecast period. The market encompasses self-monitoring blood glucose devices, continuous glucose monitoring systems, and hospital-use glucose testing equipment across home care, hospitals, clinics, and diagnostic centers.

Get detailed market forecasts, competitive benchmarking, and pricing trends:

Rising diabetes prevalence remains a central factor supporting demand for glucose monitoring technologies. Fact.MR highlights that 828 million adults were living with diabetes globally in 2024, creating a sustained need for regular glucose measurement and disease management. At the same time, declining continuous glucose monitoring costs are widening access to CGM systems, including among type 2 diabetes and previously underserved patient groups. Government-led screening and monitoring programs are also expanding procurement opportunities, particularly in high-population markets.

Self-monitoring devices are projected to account for 68% of the blood sugar tester market in 2026. Their leading position is linked to relatively low costs, broad reimbursement coverage, an established installed base, and recurring demand for test strips. While CGM adoption is gaining momentum in developed healthcare systems, traditional SMBG devices continue to serve large patient populations, particularly in markets where affordability and public procurement remain major considerations.

China is projected to record the fastest country-level growth among the markets analyzed by Fact.MR, with demand advancing at an 8.9% CAGR through 2036. The country's 2024-2030 Diabetes Action Plan supports standardized monitoring at the community level and targets more than 70% standardized management coverage for type 2 diabetes by 2030. These measures are expected to support large-scale procurement of glucose meters and strips, while updated guidelines are also promoting CGM use for type 1 diabetes.

The United States is forecast to expand at a 5.8% CAGR through 2036. Growth is being supported by strong CGM penetration, wider over-the-counter access, and regulatory developments including clearance of Dexcom's G7 15-Day sensor. Abbott's integration initiatives with Medtronic also support demand for connected CGM and automated insulin-delivery ecosystems. Germany, meanwhile, is projected to register a 5.2% CAGR, supported by broad statutory reimbursement for CGM technologies, established specialist networks, and continued competition following Roche's SmartGuide entry into the European market.

Unlock 360° insights for strategic decision making and investment planning:

The competitive environment includes Roche Diagnostics, Abbott, LifeScan, Ascensia Diabetes Care, and Dexcom. Competition spans sensor accuracy, wear duration, digital connectivity, reimbursement access, and integration with automated insulin delivery, while the SMBG segment remains more fragmented and continues to compete heavily on strip pricing and distribution reach.

As glucose monitoring moves toward a combination of high-volume SMBG consumption and increasingly accessible CGM technologies, manufacturers and healthcare stakeholders are focusing on reimbursement, public procurement, connectivity, and product accessibility. The full Fact.MR report provides detailed forecasts, segment analysis, country-level growth assessments, competitive intelligence, and technology trends for the blood sugar tester market through 2036.

Explore More Related Studies Published by Fact.MR Research

Clean Mouthfeel Lubricants Market

Perishable Demand Tools Market

Functional Chewing Gum Products Market

About Fact.MR

Fact.MR is a global market research and consulting firm, trusted by Fortune 500 companies and emerging businesses for reliable insights and strategic intelligence. With a presence across the U.S., UK, India, and Dubai, we deliver data-driven research and tailored consulting solutions across 30+ industries and 1,000+ markets. Backed by deep expertise and advanced analytics, Fact.MR helps organizations uncover opportunities, reduce risks, and make informed decisions for sustainable growth.

- Contact Us -
11140 Rockville Pike, Suite 400, Rockville,
MD 20852, United States
Tel: +1 (628) 251-1583 | [email protected]